Search Result "Kat3 coactivator."


Perspective

Convergence of Canonical and Non-Canonical Wnt Signal: Differential Kat3 Coactivator Usage

Journal: Current Molecular Pharmacology
Volume: 12 Issue: 0 Year: 2019 Page: 1-17
Author(s): Keane K.Y. Lai,Cu Nguyen,Kyung-Soon Lee,Albert Lee,David P. Lin,Jia-Ling Teo,Michael Kahn

Research Article

Specific Direct Small Molecule p300/β-Catenin Antagonists Maintain Stem Cell Potency

Journal: Current Molecular Pharmacology
Volume: 9 Issue: 3 Year: 2016 Page: 272-279
Author(s): Yusuke Higuchi, Cu Nguyen, Shin-Ya Yasuda, Michael McMillan, Kouichi Hasegawa, Michael Kahn

Hypoxia Selects for a Quiescent, CML Stem/Leukemia Initiating- Like Population Dependent on CBP/Catenin Transcription

Journal: Current Molecular Pharmacology
Volume: 6 Issue: 3 Year: 2013 Page: 204-210
Author(s): Aiko Kida,Michael Kahn

Biography free to download

Meet Our Editor-in-Chief

Journal: Current Molecular Pharmacology
Volume: 10 Issue: 3 Year: 2017 Page: 161-161
Author(s): Michael Kahn

Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5051-5064
Author(s): Luis M. Valor, Jose Viosca, Jose P. Lopez-Atalaya, Angel Barco

Research Article open access plus

E7386 is not a Specific CBP/β-Catenin Antagonist

Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-10
Author(s):

Results 1 - 1 of 7

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy